Abstract:Background: Recruitment and entrapment of bone marrow-derived endothelial progenitor cells (EPCs) is important in vascular endothelial growth factor (V-EGF)-induced angiogenesis. EPC mobilization and differentiation are modulated by stromal-derived factor-1 alpha (SDF-1 alpha/CXCL12), another important chemokine. In this study, we investigated the hypothesis that SDF-1 alpha and VEGF might act synergistically on EPC-mediated vasculogenesis.Methods: EPCs were isolated and cultured from human peripheral blood, then transduced with retroviral vectors pBabe containing human VEGF(165) complimentary DNA (Td/V-EPCs) and pBabe wild-type (Td/p-EPCs). EPC migration activity was investigated with a modified Boyden chamber assay. EPC apoptosis induced by serum starvation was studied by annexin V assays. The combined effect of local administration of SDF-1 alpha and Td/V-EPC transplantation on neovascularization was investigated in a murine model of hind limb ischemia.Results. Over-expression of hV-EGF(165) increased SDF-1 alpha-mediated EPC migration. SDF-1 alpha-mediated migration was significantly increased when EPCs were modified with VEGF (Td/V-EPCs) vs when VEGF was not present (Td/p-EPCs) or when VEGF alone was present (Td/V-EPCs; 196.8 +/- 15.2, 81.2 +/- 9.8, and 67.4 +/- 7.4/mm(2), respectively P < .001). SDF-1 alpha combined with VEGF reduced serum starvation-induced apoptosis of EPCs more than SDF-1 alpha or VEGF alone (P < .001). To determine the effect of this combination in vivo, SDF-1 alpha was locally injected alone into the ischemic hind limb muscle of nude mice or combined with systemically injected Td/V-EPCs. The SDF-1 alpha plus VEGF group showed significantly increased local accumulation of EPCs, blood-flow recovery, and capillary density compared with the other groups. The ratio of ischemic/normal blood flow in Td/V-EPCs plus SDF-1 alpha group was significantly higher (P < .01), as was capillary density (capillaries/mm(2)), an index of neovascularization (Td/V-EPCs plus SDF-1 alpha group, 863 31; no treatment, 395 +/- 13; SDF-1 alpha, 520 +/- 29; Td/p-EPCs, 448 +/- 28; Td/p-EPCs plus SDF-1 alpha., 620 +/- 29; Td/V-EPCs, 570 +/- 30; P < .01). To investigate a possible mechanistic basis, we showed that VEGF up-regulated the receptor for SDF-1 alpha, CXCR4, on EM in Nitro.Conclusion: The combination of SDF-1 alpha and VEGF greatly increases EPC-mediated angiogenesis. The use VEGF and SDF-1 alpha together, rather than alone, will be a novel and efficient angiogenesis strategy to provide therapeutic neovascularization. (J Vase Surg 2009;50:608-16.)

In Vivo Enhancement Of Angiogenesis By Adenoviral Transfer Of Hif-1 Alpha-Modified Endothelial Progenitor Cells (Ad-Hif-1 Alpha-Modified Epc For Angiogenesis)

Angiogenesis by Transplantation of HIF-1 Alpha Modified EPCs into Ischemic Limbs.

Feasibility of Hypoxia Inducible Factor Gene Transfer in Endothelial Progenitor Cell for Vascular Regeneration

Angiogenesis by hypoxia inducible factor-1α transfected endothelial progenitor cells

Therapeutic angiogenesis by transplantation of human embryonic stem cell-derived CD133+ endothelial progenitor cells for cardiac repair.

Enhancement of the Anti-Apoptotic and Angiogenic Properties of Bone Marrow-Derived Endothelial Progenitor Cells by Bcl-2 Gene Transfer in Rats

Enhancement of Viability of Fat Grafts in Nude Mice by Endothelial Progenitor Cells

Sustained Release of Stromal Cell-Derived Factor-1α from Injectable Hydrogels in Combination with Endothelial Progenitor Cells Effectively Promotes Neovascularization in Ischemic Diabetic Rats

Norepinephrine Stimulates Mobilization of Endothelial Progenitor Cells after Limb Ischemia

Treatment of Transfection Hypoxia Inducible Factor Gene into Endothelial Progenitor Cells for Vascular Regeneration in Rat Ischemic Hind-Limb

The Therapeutic Effect of Vascular Endothelial Growth Factor Gene- or Heme Oxygenase-1 Gene-Modified Endothelial Progenitor Cells on Neovascularization of Rat Hindlimb Ischemia Model.

Combination of Stromal-Derived Factor-1Α and Vascular Endothelial Growth Factor Gene-Modified Endothelial Progenitor Cells is More Effective for Ischemic Neovascularization

Enhanced Endothelial Progenitor Cell Mobilization and Function Through Direct Manipulation of Hypoxia Inducible Factor-1Α.

Hypoxic Inducible Factor 1α Gene Regulated Human Endothelial Progenitor Cells from Peripheral Blood in Hypoxia

[Overexpression of Hypoxia Inducible Factor-1Alpha (Hif-1Alpha) Promotes the Differentiation of Endothelial Progenitor Cell Ex Vivo].

Autologous transplantation of EPCs encoding FGF1 gene promotes neovascularization in a porcine model of chronic myocardial ischemia.

Kallikrein Gene-Modified EPCs Induce Angiogenesis in Rats with Ischemic Hindlimb and Correlate with Integrin Αvβ3 Expression.

Inhibition of Hypoxia-Inducible Factor-1α and Endothelial Progenitor Cell Differentiation by Adenoviral Transfer of Small Interfering RNA in Vitro

Optimization of Adenovirus-Mediated Endothelial Nitric Oxide Synthase Delivery in Rat Hindlimb Ischemia

Transplantation of Endothelial Progenitor Cells from Peripheral Blood Enhancing Neovascularization in Ischemic Tissue of Nude Mice

Vascular Endothelial Grow Factor 165 and Angiopoitin-1 Augment Revascularization in a Rat Hindlimb Ischemia Model